Smart Moves at Year-End
Patient Advocacy Strategies To Set You Up for 2026 and Beyond This time of year, many in pharma and biotech are looking at budgets with an eye toward action: what…
Read More
Blog
Is Patient Advocacy in Danger of Stalling Out?
This is a challenging time to be a patient or a patient advocate. Extensive cuts at NIH and FDA, a retraction of DEI commitments, major universities losing their funding—all threaten…
Read More
Colin Farrell’s New Foundation: A Powerful Reminder of Advocacy’s Roots
Over the past couple of weeks, the media was filled with articles and clips of actor Colin Farrell. He wasn’t promoting a new movie this time, but bringing his considerable…
It’s Complicated: The Industry/Patient Advocacy Organization Relationship
Last week, Adam Feuerstein of STAT+ posted a news story that underscored the complexity of relationships between patient organizations and pharmaceutical companies. See story here. According to STAT, the…
- by: Heidi Adams
August 5, 2024
Joint Statement from Pyxis Partners and Rx4good on New Details Regarding FDA Requirements on Diversity Action Plans for Certain Clinical Studies
As partners dedicated to advancing diversity and inclusivity in clinical trials, Pyxis Partners and Rx4good welcome the recently released U.S. Food and Drug Administration (FDA) draft guidance on diversity action plan requirements for…
